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Abstract
Ildr2, a modifier of diabetes susceptibility in obese mice, is expressed in most organs, including islets and hypothalamus,
with reduced levels in livers of diabetes-susceptible B6.DBA mice congenic for a 1.8 Mb interval of Chromosome 1. In
hepatoma and neuronal cells, ILDR2 is primarily located in the endoplasmic reticulum membrane. We used adenovirus
vectors that express shRNA or are driven by the CMV promoter, respectively, to knockdown or overexpress Ildr2 in livers of
wild type and ob/ob mice. Livers in knockdown mice were steatotic, with increased hepatic and circulating triglycerides and
total cholesterol. Increased circulating VLDL, without reduction in triglyceride clearance suggests an effect of reduced
hepatic ILDR2 on hepatic cholesterol clearance. In animals that overexpress Ildr2, hepatic triglyceride and total cholesterol
levels were reduced, and strikingly so in ob/ob mice. There were no significant changes in body weight, energy expenditure
or glucose/insulin homeostasis in knockdown or overexpressing mice. Knockdown mice showed reduced expression of
genes mediating synthesis and oxidation of hepatic lipids, suggesting secondary suppression in response to increased
hepatic lipid content. In Ildr2-overexpressing ob/ob mice, in association with reduced liver fat content, levels of transcripts
related to neutral lipid synthesis and cholesterol were increased, suggesting ‘‘relief’’ of the secondary suppression imposed
by lipid accumulation. Considering the fixed location of ILDR2 in the endoplasmic reticulum, we investigated the possible
participation of ILDR2 in ER stress responses. In general, Ildr2 overexpression was associated with increases, and knockdown
with decreases in levels of expression of molecular components of canonical ER stress pathways. We conclude that
manipulation of Ildr2 expression in liver affects both lipid homeostasis and ER stress pathways. Given these reciprocal
interactions, and the relatively extended time-course over which these studies were conducted, we cannot assign causal
primacy to either the effects on hepatic lipid homeostasis or ER stress responses.
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Introduction
In an earlier study [1] we exploited the differential diabetes
susceptibilities of mouse strains C57BL/6J (B6) and DBA/2J
(DBA) [2] segregating for the obesity mutation, Lepob, to identify a
gene that encodes a predicted single-pass, trans-membrane
molecule that, in B6.DBA congenic mice (segregating a DBA
haplotype in a 1.8 Mb interval on Chr1), was associated with
reduced b-cell replication rates accompanied by reduced b-cell
mass, and persistent mild hypoinsulinemic hyperglycemia. This
gene, formerly designated ‘‘Lisch-like’’, has been renamed ‘‘immu-
noglobulin-like domain containing receptor 20 (Ildr2) [http://
www.informatics.jax.org/mgihome/nomen/] to reflect the simi-
larity of the conserved domain structure of the cognate protein to
the two other members of this gene family: Ildr1 and Ildr3 (aka
‘‘LSR’’ – lipolysis stimulated receptor).
Despite their structural similarities, the three Ildr-genes exhibit
widely divergent tissue-specific expression profiles, providing little
evidence of significant overlap among their functions. The major
isoforms of both ILDR1 and ILDR3 localize either to the plasma
membrane (PM) or to the cytosol [3,4]. Although ILDR1 has been
linked to neoplastic disease 2 [5] and non-syndromic deafness [6],
how it functions is unknown. ILDR3, which was initially identified
as a fatty acid-activated, liver-specific lipoprotein receptor [7], has
since been characterized variously as a receptor for Clostridium
toxin [8], as an hepatic receptor upregulated by leptin [9] and as a
component of tri-cellular junctions in epithelial cells [10].
The Ildr2 gene is widely expressed, with 4 major isoforms that
are differentially expressed in tissues relevant to the diabetic
phenotype (hypothalamus, liver and islet b-cells). Expression levels
of isoform 4, highest in liver, are reduced 20-fold in B6.DBA
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congenic animals and 30-fold in 10-week-old DBA mice versus B6
animals [1]. To assess the role of Ildr2 in the molecular physiology
of normal, adult liver, we used intravenously administered
adenoviruses containing overexpression or knockdown constructs
to study in vivo effects in liver and whole animal, and in transduced
primary hepatocytes to study in vitro effects.
Here we report that ILDR2, in contrast to ILDR1 and ILDR3,
is exclusively localized in the endoplasmic reticulum (ER), where it
apparently participates in both lipoprotein physiology and the ER
stress response, with consequences for hepatic lipid homeostasis.
Results
ILDR2 is Localized to the Endoplasmic Reticulum
As previously described [1], the four major isoforms of ILDR2
(Figure 1) contain an amino terminal immunoglobulin-like
domain and long, carboxy tail. Isoforms 1, 2, and 4 also contain
a single trans-membrane (TM) domain. Isoform 1 is full-length;
isoform 2 lacks exon 6 (carboxy to the TM domain); isoform 4
lacks exon 4 (amino to the TM domain); isoform 3 lacks the TM
domain and both flanking exons.
To determine the cellular location(s) of ILDR2, various isoforms
were tagged at the C-termini with the green variant of the
monomeric yellow fluorescent protein (mYFP), transiently trans-
duced into mouse cells, and analyzed by confocal microscopy for
co-localization with probes for the ER and PM (Figure 2). Ildr2-
isoform 2, predominantly expressed in the hypothalamus, was
transduced into cells of the mouse hypothalamic neuronal cell line
GT1-7 (Figure 2A). Ildr2-isoform 4, the predominant isoform
endogenously expressed in the liver, was transduced into cells of
the mouse hepatoma cell line, Hepa1c1c7 (Figure 2B). Both
isoforms localized solely to the ER membrane, with no detectable
fluorescence in the vicinity of the PM. Placement of the tagging
peptide did not affect subcellular destination, since localization to
the ER membrane was seen also in Hepa1c1c7 cells transduced
with Ildr2-isoform 1 tagged at its N-terminus with the FLAG
epitope (Figure 2C). These results support the model depicted in
Figure 1, in which the hydrophobic, amino-terminal, immuno-
globulin-like domain of isoforms 1, 2 and 4, extends into the ER
lumen, and the hydrophilic carboxy-terminal tail, extends into the
cytoplasm. We also observed no changes in the subcellular
distribution of C-terminal tagged isoform 4 in Hepa1c1c7
transfectants that were exposed to glucose, insulin, free fatty acids
(FFA), and low-density lipoprotein (LDL) (data not shown). These
results suggest that, unlike ILDR1 and ILDR3, whose final
destination is the PM, ILDR2 is an integral ER trans-membrane
molecule that likely does not further translocate within these cell
types.
Functional Analysis of Ildr2
The ER plays critical roles in protein and lipid synthesis,
lipoprotein assembly and export, glucose and calcium homeostasis,
and cellular responses to metabolic stress [11–15]. These protean
functions affect liver [16], hypothalamus [17], and b-cells [18].
The metabolic phenotypes seen in the Ildr2 B6.DBA.congenic lines
are consistent with effects on ER stress mechanisms [1].
Accessibility of the liver to in vivo and in vitro transcriptional
manipulation using adenovirus vectors [19,20], led us to focus on
the liver.
To examine the effects of short term changes in Ildr2 expression
in liver on lipid and glucose homeostasis, 10-week-old chow-fed
C57BL/6J (wild-type; WT) or B6.Cg-Lepob/J (obese; OB) male
mice were transduced with adenoviral expression vectors encoding
shRNA (‘‘ADKD’’) that knockdown Ildr2, or with adenoviral
constructs driven by the CMV promoter (‘‘ADOX’’) that
overexpress Ildr2. To control for non-specific effects of adenoviral
transduction on gene expression, we also transduced mice with
adenoviral expression vectors encoding shRNA that knockdown
lacZ, or with adenoviral constructs driven by the CMV promoter
that overexpress the green fluorescent protein (GFP). Expression
levels in the hypothalamus and white adipose tissue were
unaffected by transduction with either the ADKD or ADOX
viral constructs (data not shown), confirming that their effects were
restricted primarily to the liver. Knockdown efficiency exceeded
80% at 3 days post-transduction (p.t.) and 90% at 10 days p.t.,
while Ildr2 overexpression resulted in 2- to 4-fold increases in
mRNA levels.
For studies of liver morphology, histology and chemistry, and
for liver-specific gene expression analysis, animals were sacrificed
Figure 1. Predicted structure of major ILDR2 isoforms. Isoform 1 (GenBank: FJ024495.1) is full-length. There are 10 predicted exons. Exon 1 is
an amino terminal signal peptide; exons 2 and 3 code for an IgV-like immunoglobulin domain; exon 4 is amino proximal to the trans-membrane
domain of exon 5; exons 6–10 comprise a randomly-coiled, carboxy-terminal tail (simplified in this depiction as rod-like). Based on results shown in
Figure 2, exons 1–4 are lumenal and exons 6–10 are cytosolic. Isoform 2 (GenBank: FJ024496.1) lacks cytosolic exon 6. Isoform 4 (GenBank:
FJ024498.1) lacks lumenal exon 4. Isoform 3 (GenBank: FJ024497.1) lacks exons 4, 5, and 6 and, therefore has no trans-membrane domain, and is
depicted as entirely cytosolic.
doi:10.1371/journal.pone.0067234.g001
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at 3 days or 10 days p.t. To provide a general picture of the
cellular/biochemical consequences of manipulations of expression
of hepatic Ildr2, we evaluated the livers by visual inspection, light
microscopy, chemical composition, and by quantitative expression
of selected genes related to neutral lipid/cholesterol synthesis, lipid
oxidation, glucose homeostasis, and ER stress. Mice were also
evaluated by indirect calorimetry, ipGTT, and plasma lipid
profiling. To identify very short term responses to changes in
expression of Ildr2, we transduced mouse primary hepatocytes with
the ADKD and ADOX constructs and analyzed responses at
24 hr p.t.
Ildr2 does not Cross-regulate with Ildr1 or Ildr3
Although the apparent lack of cellular colocalization of ILDR2
with other molecules of this family makes it unlikely that ILDR2
interacts directly with them, its functions could be mediated
through secondary genetic effects. To test this possibility we
analyzed transcription levels among the ildr genes in primary B6
mouse hepatocytes transduced with siRNAs specific to each gene
(Table 1). Whereas siRNA specific to Ildr2 almost completely
suppressed its own expression, it reduced expression of Ildr1 by
only 3% and Ildr3 by 27%, with little effect on Ildr2 of knockdown
of either Ildr1 or Ildr3. These results indicate that expression levels
of Ildr genes do not significantly cross-regulate.
Changes in Ildr2 Expression Affect Liver Morphology and
Histology
Control WT livers (lacZ) were normal in size and appearance in
WT animals at 3 and 10 days p.t. but, as expected, were enlarged
and grossly steatotic in OB animals (Figure 3). The ADKD livers
(WT and OB) were enlarged and grossly steatotic, whereas the
ADOX WT livers were generally normal in appearance and size
as were, remarkably, the ADOX OB livers.
Control WT livers were histologically normal with the exception
of occasional mild lipid vesiculation and attendant monocytic
infiltration, presumably due to adenovirus transduction per se. As
anticipated, OB control livers showed extensive large vacuoliza-
tion with minimal focal lobular lymphocytic infiltration [21].
Livers of ADKD WT mice at 3 days p.t. (Figure 3A) showed
mildly increased periportal vacuolization, modest mononuclear
infiltration, occasional apoptosis and autophagy. By 10 days p.t.
(Figure 3B), histologic changes were striking: smaller lipid vesicles
in the periportal region progressed to larger droplets at a distance
from the portal tract, with ballooning of hepatocytes, autophagy,
apoptosis and periportal monocytic inflammation. Some cells
showed clumped pink intermediate filaments resembling human
Mallory-Denk bodies in steatohepatitis, where they signify
hepatocellular oxidative stress [22]. In the fed ADKD animals,
increased apoptosis and inflammation were apparent in the
context of a preponderance of large droplet fat vesicles. Lobular
inflammation reminiscent of human non-alcoholic steatohepatitis
was also seen. The livers of ADKD OB mice at 10 days p.t.
(Figure 3C) displayed extensive lipid deposition, with micro-
vesiculation accompanied by severe monocytic infiltration, and
areas of fibrosis in some animals.
In ADOX WT animals, phenotypic effects were generally
modest. At 3 days p.t. (Figure 3D), livers showed mild, small
droplet steatosis, but by 10 days p.t. (Figure 3E), there were areas
of increased apoptosis with minimal lipid deposition or inflam-
mation, consistent with a primary effect on ER stress-related
responses. In fed animals, glycogen deposition was greatly
increased. ADOX OB animals at 10 days p.t. (Figure 3F) showed
substantial reduction in the severity of steatosis (mostly medium
and large droplet) with virtually no inflammation or apoptosis.
These changes represented a striking ‘‘rescue’’ of the histology
seen in the OB control and KD animals.
These gross effects and microscopic characteristics indicate the
importance of Ildr2 in hepatic lipid homeostasis, with reduced
expression causing lipid accumulation and overexpression acting
to reduce this excess in OB livers. These effects generally increased
in severity between 3 and 10 days p.t. Potential mechanisms for
these effects and their molecular and physiological consequences
were investigated.
Liver and Plasma Chemistry
Hepatic triglyceride (TG) content was generally consistent with
the histological effects of ADKD (Tables 2, 3, and 4) and
ADOX (Tables 5, 6, and 7), whereas plasma TG, FFA, and
Figure 2. Fluorescence microscopy of ILDR2 localization under basal conditions. ILDR2 fused on its C-terminus to mYFP (green) was
transiently co-transduced into cell lines with DsRed-probes specific to either the ER (red) or the PM (red). The ER-specific probe is DsRed fluorescent
protein attached to the ER-retention sequence KDEL. The PM-specific probe is DsRED attached to a farnesyl group that targets the protein to the
inner leaflet of the PM. Cells were fixed without any further treatment 24 hr after transfection. Bar: 100 uM. Confocal images recorded at 636
magnification. (A) GT1-7 cells. ILDR2-isoform 2-YFP merges with DsRed-ER probe to produce a yellow signal over the ER, but does not merge with the
red DsRed-PM probe. (B) Hepa1c1c7 cells. The green ILDR2-isoform 4-YFP probe merges with the red DsRed-ER probe to produce an orange signal
over the ER; expression levels of labeled proteins are less uniform than in GT1-7 cells. The red DsRed-PM and green ILDR2-YFP signals do not merge in
the PM. (C) Hepa1c1c7 cells. N-terminal fusion of ILDR2-isoform 1 with 3xFLAG epitope co-transduced with DsRed-probes to ER. Tag geometry does
not interfere with subcellular localization.
doi:10.1371/journal.pone.0067234.g002
Table 1. Relative expression of Ildr-family genes transduced with Ildr-siRNAs.
Ildr1 siRNA (n=3) Ildr2 siRNA (n=10) Ildr3 siRNA (n=3)
Gene Relative Expression P-value Relative Expression P-value Relative Expression P-value
Ildr1 0.14 1.2 E-03 0.97 NS ND NA
Ildr2 0.97 NS 0.03 6.5 E-06 1.28 3.3 E-03
Ildr3 ND n/a 0.73 8.0 E-05 0.03 3.4 E-03
Genes of the Ildr-family do not significantly cross-regulate. Data for effects of Ildr1 and Ildr3 siRNAs were determined by qPCR. Data for effects of Ildr2 siRNA are from
microarray. Levels of mRNA are normalized to the 36B4 ribosomal housekeeping gene, expressed relative to levels of each gene in control cells transduced with a
scrambled, non-specific siRNA sequence. n/a: not applicable; ND: not done; NS: not significant.
doi:10.1371/journal.pone.0067234.t001
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glucose/insulin-related measurements were minimally affected. In
contrast, hepatic and plasma cholesterol were greatly increased in
refed 10 day ADKD animals. These phenotypes are described in
more detail below.
At 3 days p.t. in ADKD WT animals (Table 2), body weight,
liver weight and liver total cholesterol (TCH) content were
unaffected, as were circulating concentrations of glucose, insulin,
TG, TCH, and FFA. However, hepatic TG and glycogen content
were significantly increased. Estimates of insulin resistance by
HOMA2-IR and b-cell function by HOMA-2B% were unaffected,
as were glucose excursions during IPGTT (see below). At 10 days
p.t. in ADKD WT animals (Table 3), hepatic and circulating
TCH and hepatic TG were increased while circulating TG was
unchanged. Again, HOMA measurements were unaffected. In
ADKD OB mice at 10 days p.t. (Table 4), - starting from higher
baselines (as expected vs. WT animals) [21] - liver weight, TG and
TCH content increased, and glycogen content decreased. Circu-
lating concentrations of glucose, insulin, TG, TCH, and IPGTT
were unaffected; circulating FFA concentrations were increased.
In ADOX WT animals at 3 days p.t. (Table 5), TG and TCH
concentrations per unit wet weight of liver were higher (and
glycogen lower) than in control mice. Plasma lipids were
unaffected by ADOX. At 10 days p.t. in ADOX WT mice
(Table 6), liver TG was lower, and glycogen content higher than
in controls. Plasma TG and TCH trended higher in the ADOX
animals. At 10 days p.t. in ADOX OB mice (Table 7), liver TG
and TCH content were reduced without significant changes in
circulating glucose, TG, TCH or FFA. Hepatic glycogen per gram
wet weight was unaffected but, given the considerable reduction of
TG, was probably decreased per unit liver nitrogen. Measure-
ments of blood ALT and AST enzyme levels in these animals
Figure 3. Liver morphology and histology in ADKD and ADOX WT and OB mice. Chow-fed, 10-week-old B6 males were sacrificed after 24-
hr fast (Fasted) or following a 24-hr fast and 12-hr refeeding (Refed). Liver morphology is shown in the upper panels and hematoxylin and eosin
staining of representative sections is shown in the lower panels at 200X magnification (scale is 100 mm). Asterisk (*) identifies large droplet,
macrovesicular lipid vacuoles, particularly evident in Ob sections; large open arrows (M-D) denote intra-hepatocellular Mallory-Denk-like eosinophilic
material; open yellow arrows (mF) denote small droplet, microvesicular fat within hepatocytes; short double black arrows (iMO) indicate mononuclear
inflammatory cells, consistent with lymphocytes; large blue arrows (ap) indicate apoptotic hepatocytes; (glyc) identifies a ‘‘clear’’-appearing
hepatocyte with increased glycogen content (e.g., ADOX WT 10d Refed); Portal Tract (or PT) is above the hatched line in ADKD WT 10d Fasted); (CV) is
Central Vein; (PV) is Portal Vein; (BD) is Bile Duct. (A) Wild-type mice, 3 days p.t. with adenovirus knockdown vectors expressing RNAi for lacZ or Ildr2
(B) Wild-type mice, 10 days p.t. with adenovirus knockdown vectors expressing RNAi for lacZ or Ildr2 (C) ob/ob mice, 10 days p.t. with adenovirus
knockdown vectors expressing RNAi for lacZ or Ildr2 (D) Wild-type mice, 3 days p.t. with adenovirus vector over-expressing GFP or Ildr2; there is no
significant steatosis or inflammation (E) Wild-type mice, 10 days p.t. with adenovirus vector over-expressing GFP or Ildr2 (F) ob/ob mice, 10 days p.t.
with adenovirus vector over-expressing GFP or Ildr2. As described in the text, increased apoptosis without inflammation is consistent with a primary
role for ILDR2 in ER stress responses.
doi:10.1371/journal.pone.0067234.g003
Table 2. Liver and plasma chemistries of ADKD WT mice at 3
days p.t.
ADKD WT 3 D
Fasted
Phenotype (n) lacZ (10) Ildr2 (10) P-value
Body weight (g) 25.960.5 25.760.8 0.831
Liver weight (g) 1.260.0 1.260.0 0.772
Hepatic TG (mg/g Liver) 53.765.1 69.263.1 0.018
Hepatic TCH (mg/g Liver) 6.760.1 7.260.3 0.268
Hepatic glycogen (mg/g Liver) 8.662.0 20.262.9 0.008
Plasma glucose (mg/dL) 182610 216616 0.096
Plasma insulin (mg/L) 0.1560.04 0.2660.06 0.190
Plasma TG (mg/dL) 156.8629.7 157.3620.0 0.989
Plasma TCH (mg/dL) 67.461.4 70.862.4 0.250
Plasma FFA (mEq/L) 1.2760.03 1.2960.02 0.564
Plasma ALT (mU/L) 134.3610.3 126.267.8 0.064
Plasma AST (mU/L) 125.568.0 126.867.3 0.707
HOMA2-IR 0.5960.17 1.1160.33 0.178
HOMA2-B (%) 14.363.3 16.562.8 0.598
Mice were chow-fed, 10-week-old B6 (WT) males, intravenously injected with
ADKD vectors expressing RNAi for lacZ or Ildr2. Measurements were taken at 3
days p.t. (following a 12-hr fast). n = number of animals in each study. Data
shown are mean 6 SEM; P values were calculated by 2-tailed t test. FFA, free
fatty acids; ALT, alanine aminotransferase; AST, aspartate aminotransferase;
HOMA2-IR, homeostasis model assessment-estimated insulin resistance; HOMA-
2-B (%), homeostasis model assessment-b-cell function.
doi:10.1371/journal.pone.0067234.t002
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indicate that toxic effects of the adenoviral transductions on
hepatocyte integrity were minimal.
Analysis of in vivo Lipoprotein Production and Clearance
The increase in hepatic TG and TCH in the ADKD mice could
reflect: 1. increased assembly/reduced secretion of lipoproteins; 2.
increased synthesis/decreased oxidation of TG; 3. increased
synthesis/decreased disposal of cholesterol. Detergents such as
Triton WR1339 block clearance of TG in circulating lipoproteins
by inhibiting lipoprotein lipase (LPL)-mediated lipolysis of
circulating TG-rich lipoproteins [23]. When LPL is inhibited,
changes in circulating concentrations of lipoprotein species reflect
Table 3. Liver and plasma chemistries of ADKD WT mice at 10 days p.t.
ADKD WT 10 D
Fasted Refed
Phenotype (n) lacZ (5) Ildr2 (6) P-value lacZ (5) Ildr2 (6) P-value
Body weight (g) 25.1 27.5 0.084 27.5 27.5 0.983
Liver weight (g) 1.3 2.1 0.000 2.1 2.5 0.096
Hepatic TG (mg/g Liver) 46.462.9 88.666.5 0.001 18.662.8 76.967.0 0.000
Hepatic TCH (mg/g Liver) 9.860.6 18.061.7 0.005 7.660.4 14.861.4 0.003
Hepatic glycogen (mg/g Liver) 1.960.2 3.260.5 0.039 58.063.6 37.162.1 0.007
Plasma glucose (mg/dL) 8167 8663 0.619 18765 15368 0.009
Plasma insulin (mg/L) 0.2660.10 0.2560.02 0.903 4.9160.75 5.9961.68 0.576
Plasma TG (mg/dL) 114.2619.0 138.0617.0 0.362 203.8622.9 243.0627.0 0.275
Plasma TCH (mg/dL) 131.764.0 254.0624.8 0.003 135.568.8 313.3632.4 0.001
Plasma FFA (mEq/L) 1.5260.06 1.2560.13 0.093 1.0560.18 0.7260.03 0.150
Plasma ALT (mU/L) 44.566.2 51.169.3 0.598 46.663.0 48.366.0 0.812
Plasma AST (mU/L) 46.566.8 48.869.2 0.852 49.663.7 47.566.5 0.797
HOMA2-IR 0.8560.35 0.8060.09 0.901 n/a n/a n/a
HOMA2-B (%) 94.4622.2 91.069.0 0.989 n/a n/a n/a
Mice were chow-fed, 10-week-old B6 (WT) males, intravenously injected with ADKD vectors expressing RNAi for lacZ or Ildr2. Measurements were taken at 10 days p.t.
(following either a 24-hr fast ‘‘Fasted’’ or following a 24-hr fast and 12-hr refeeding ‘‘Refed’’). n = number of animals in each study. n/a: not applicable. Data shown are
mean 6 SEM; P values were calculated by 2-tailed t test. TG, triglycerides; TCH, total cholesterol; FFA, free fatty acids; ALT, alanine aminotransferase; AST, aspartate
aminotransferase; HOMA2-IR, homeostasis model assessment-estimated insulin resistance; HOMA-2-B (%), homeostasis model assessment-b- cell function. In
contemporaneous experiments in our laboratory, B6 mice fasted for 12 hr and not treated with adenovirus had plasma ALT of 86.0 mU/L and AST of 94.6 mU/L.
doi:10.1371/journal.pone.0067234.t003
Table 4. Liver and plasma chemistries of ADKD OB mice at 10 days p.t.
ADKD OB 10 D
Fasted Refed
Phenotype (n) lacZ (3) Ildr2 (4) P-value lacZ (3) Ildr2 (4) P-value
Body weight (g) 46.760.4 46.860.9 0.961 46.463.1 47.361.9 0.845
Liver weight (g) 4.260.5 5.860.3 0.012 3.460.1 6.460.7 0.047
Hepatic TG (mg/g Liver) 77.564.0 113.766.8 0.037 77.061.0 118.067.3 0.041
Hepatic TCH (mg/g Liver) 10.661.5 16.563.4 0.189 8.960.7 16.963.6 0.203
Hepatic glycogen (mg/g Liver) 43.060.4 14.663.8 0.004 44.261.9 5.861.3 0.001
Plasma glucose (mg/dL) 175629 116620 0.215 379679 214628 0.233
Plasma insulin (mg/L) 18.1610.1 27.2619.5 0.707 77.8633.1 103.565.3 0.576
Plasma TG (mg/dL) 97.6628.0 133.5616.1 0.395 121.0624.5 195.4624.2 0.135
Plasma TCH (mg/dL) 110.362.5 104.062.5 0.173 112.669.7 133.768.5 0.231
Plasma FFA (mEq/L) 1.2360.01 1.7160.08 0.012 1.3160.07 2.4460.16 0.013
Plasma ALT (mU/L) 93.264.0 107.264.1 0.006 105.969.6 126.8625.3 0.274
Plasma AST (mU/L) 88.962.3 110.0611.3 0.036 93.4610.6 115.8637.1 0.421
Mice were chow-fed, 10-week-old B6.V-Lepob/J (OB) males, intravenously injected with ADKD vectors expressing RNAi for lacZ or Ildr2. Measurements were taken at 10
days p.t. (following either a 24-hr fast ‘‘Fasted’’ or following a 24- hr fast and 12-hr refeeding ‘‘Refed’’). n = number of animals in each study. Data shown are mean 6
SEM; P values were calculated by 2-tailed t test. TG, triglycerides; TCH, total cholesterol; FFA, free fatty acids; ALT, alanine aminotransferase; AST, aspartate
aminotransferase.
doi:10.1371/journal.pone.0067234.t004
ILDR2 and Hepatic Lipid Homeostasis
PLOS ONE | www.plosone.org 6 June 2013 | Volume 8 | Issue 6 | e67234
hepatic secretion rates of very low-density lipoprotein (VLDL). We
measured concentrations of plasma TG following LPL inhibition
with Triton WR1339 in 10-week-old chow fed ADKD and
ADOX WT mice at 7 days p.t. (Figure 4). Area under the curve
(AUC) analysis of hepatic lipoprotein secretion shows no
significant difference in either ADKD (Figure 4A) or ADOX
mice (Figure 4B). These results suggest that in ADKD mice, the
increased hepatic lipids did not stimulate increased VLDL
secretion and that, consequently, the increased plasma lipids,
notably TCH, reflected reduced hepatic lipoprotein clearance.
Likewise, the decreased hepatic lipids in ADOX mice were not
due to increased VLDL secretion. Increased hepatic lipid synthesis
in ADKD mice was not coupled to secretion or decreased hepatic
fatty acid oxidation. In contrast, ADOX mice could have had
decreased hepatic lipid synthesis or increased fatty acid oxidation.
Finally, it is interesting to note that in these animals, glucose
tolerance was normal despite severe hepatic steatosis [24].
Steady-state Lipoprotein Analysis
Based upon the striking changes in hepatic lipid content without
evidence of change in lipoprotein export, we were interested in
qualitative and quantitative changes in circulating lipoproteins in
response to transient manipulations of Ildr2 expression. We were
particularly interested in determining if the dramatic increase in
TCH in the ADKD mice represented increased TCH in VLDL or
LDL, or decreased TCH in high-density lipoprotein (HDL). In
analysis by fast protein liquid chromatography (FPLC) of fasted
plasma obtained prior to the Triton study (Figure 5), VLDL
cholesterol (fractions 12–16) and IDL/LDL cholesterol (fractions
17–23) were clearly higher, and HDL cholesterol (fractions 24–30)
was ,20% lower in the ADKD animals (Figure 5A, 5C). In
ADOX animals (Figure 5B, 5D), VLDL was similarly increased,
LDL was not altered, and HDL was also slightly reduced. These
results are consistent with the data reported in Tables 2, 3, 4, 5,
Table 5. Liver and plasma chemistries of ADOX WT mice at 3
days p.t.
ADOX WT 3 D
Fasted
Phenotype (n) GFP (9) Ildr2 (9) P- value
Body weight (g) 25.160.7 24.360.6 0.439
Liver weight (g) 1.260.0 1.060.0 0.004
Hepatic TG (mg/g Liver) 93.0611.9 124.369.6 0.073
Hepatic TCH (mg/g Liver) 10.761.2 15.661.6 0.038
Hepatic glycogen (mg/g Liver) 14.662.2 6.262.1 0.009
Plasma glucose (mg/dL) 15966 166613 0.637
Plasma insulin (mg/L) 0.1560.04 0.2160.04 0.316
Plasma TG (mg/dL) 127.3621.9 153.3614.2 0.338
Plasma TCH (mg/dL) 65.360.9 72.162.8 0.052
Plasma FFA (mEq/L) 1.2860.03 1.3560.09 0.502
Plasma ALT (mU/L) 79.5615.1 99.4613.1 0.008
Plasma AST (mU/L) 78.0620.5 93.3613.0 0.089
HOMA2-IR 0.5660.16 0.7960.15 0.347
HOMA2-B (%) 17.763.8 23.564.7 0.302
Mice were chow-fed, 10-week-old B6 (WT) males, intravenously injected with
ADOX vectors expressing GFP or Ildr2. Measurements were taken at 3 days p.t.
(following a 12-hr fast). n = number of animals in each study. Data shown are
mean 6 SEM; P values were calculated by 2-tailed t test. TG, triglycerides; TCH,
total cholesterol; FFA, free fatty acids; ALT, alanine aminotransferase; AST,
aspartate aminotransferase; HOMA2-IR, homeostasis model assessment-
estimated insulin resistance; HOMA-2-B (%), homeostasis model assessment- b-
cell function.
doi:10.1371/journal.pone.0067234.t005
Table 6. Liver and plasma chemistries of ADOX WT mice at 10 days p.t.
ADOX WT 10 D
Fasted Refed
Phenotype (n) GFP (5) Ildr2 (6) P-value GFP (5) Ildr2 (6) P-value
Body weight (g) 24.1 23.2 0.607 27.5 26.0 0.112
Liver weight (g) 1.0 1.3 0.011 1.7 2.2 0.030
Hepatic TG (mg/g Liver) 64.966.9 33.064.7 0.004 31.365.5 20.065.6 0.191
Hepatic TCH (mg/g Liver) 11.460.8 7.460.6 0.005 6.860.7 5.460.9 0.272
Hepatic glycogen (mg/g Liver) 1.160.3 4.060.9 0.033 63.061.3 71.260.4 0.048
Plasma glucose (mg/dL) 10564 9264 0.056 21164 15563 0.001
Plasma insulin (mg/L) 0.3460.09 0.3460.07 0.988 5.6760.09 4.9560.07 0.560
Plasma TG (mg/dL) 57.662.5 9869.6 0.005 192.8623.0 246.1622.4 0.117
Plasma TCH (mg/dL) 114.668.9 123.9611.6 0.563 125.762.3 145.761.2 0.005
Plasma FFA (mEq/L) 1.2560.16 1.7060.19 0.148 0.6560.18 0.8260.10 0.470
Plasma ALT (mU/L) 66.965.1 32.160.3 0.021 72.266.3 41.161.9 0.042
Plasma AST (mU/L) 65.663.7 31.460.5 0.012 68.066.2 41.162.7 0.028
HOMA2-IR 1.3660.25 1.1060.19 0.435 n/a n/a n/a
HOMA2-B (%) 86.0614.8 100.0618.8 0.570 n/a n/a n/a
Mice were chow-fed, 10-week-old B6 (WT) males, intravenously injected with ADOX vectors expressing GFP or Ildr2. Measurements were taken at 10 days p.t. (following
either a 24-hr fast ‘‘Fasted’’ or following a 24-hr fast and 12-hr refeeding ‘‘Refed’’). n = number of animals in each study. n/a: not applicable. Data shown are mean6 SEM;
P values were calculated by 2-tailed t test. TG, triglycerides; TCH, total cholesterol; FFA, free fatty acids; ALT, alanine aminotransferase; AST, aspartate aminotransferase;
HOMA2-IR, homeostasis model assessment-estimated insulin resistance; HOMA-2-B (%), homeostasis model assessment-b-cell function.
doi:10.1371/journal.pone.0067234.t006
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6, and 7, in which ADKD animals had higher absolute
circulating TG than ADOX animals and where WT fasted and
refed ADKD mice exhibited increases in plasma TCH and TG vs.
controls, whereas WT ADOX mice exhibited more moderate
changes.
Hepatic Gene-expression Signatures
To assess possible molecular bases for these changes in liver
histology and lipid/glycogen chemistry with the remarkably
minimal effects of these changes on systemic lipid and insulin
homeostasis, we examined hepatic expression of genes related to
acylglyceride, cholesterol and glucose homeostasis and ER-
resident molecules mediating responses to metabolic stress
(Figure 6).
In ADKD WT animals, at 3 days p.t. (Figure 6A), increases in
transcript levels of genes involved in acylglyceride synthesis were
consistent with increased TG content; however, at 10 days p.t.
(Figure 6B), transcripts of genes related to acylglyceride synthesis
were reduced (where Fas expression was especially decreased in
the fed animals), as were genes related to cholesterol homeostasis
Table 7. Liver and plasma chemistries of ADOX OB mice at 10 days p.t.
ADOX OB 10 D
Fasted Refed
Phenotype (n) GFP (4) Ildr2 (4) P-value GFP (4) Ildr2 (4) P-value
Body weight (g) 45.161.4 48.260.6 0.120 46.961.1 43.760.8 0.066
Liver weight (g) 3.460.2 3.960.3 0.321 4.660.3 3.460.1 0.042
Hepatic TG (mg/g Liver) 49.565.7 27.163.0 0.019 56.464.4 32.364.0 0.007
Hepatic TCH (mg/g Liver) 7.760.6 5.660.2 0.038 6.460.2 5.160.29 0.015
Hepatic glycogen (mg/g Liver) 50.464.3 53.563.7 0.606 62.86101.6 61.36103.6 0.689
Plasma glucose (mg/dL) 151610 174624 0.420 224629 263620 0.349
Plasma insulin (mg/L) 13.664.4 24.562.5 0.168 73.9619.1 89.364.0 0.489
Plasma TG (mg/dL) 94.3627.2 129.8643.4 0.538 137.6618.3 135.4611.7 0.925
Plasma TCH (mg/dL) 134.063.5 129.063.9 0.383 143.164.8 130.962.6 0.086
Plasma FFA (mEq/L) 1.6660.09 1.4660.05 0.119 2.2560.29 1.7660.12 0.206
Plasma ALT (mU/L) 115.1618.4 109.7615.7 0.668 108.065.4 100.1615.3 0.386
Plasma AST (mU/L) 106.168.8 101.7613.8 0.611 102.7612.7 98.7617.0 0.718
Mice were chow-fed, 10-week-old B6.V-Lepob/J (OB) males, intravenously injected with ADOX vectors expressing GFP or Ildr2. Measurements were taken at 10 days p.t.
(following either a 24-hr fast ‘‘Fasted’’ or following a 24 hr fast and 12 hr refeeding ‘‘Refed’’). n = number of animals in each study. Data shown are mean6 SEM; P values
were calculated by 2-tailed t test. TG, triglycerides; TCH, total cholesterol; FFA, free fatty acids; ALT, alanine aminotransferase; AST, aspartate aminotransferase.
doi:10.1371/journal.pone.0067234.t007
Figure 4. TG secretion analysis in ADKD and ADOXWTmice. Chow-fed, 10-week-old B6 (WT) males were intravenously injected with ADKD or
ADOX vectors expressing RNAi for lacZ or Ildr2. At 7 days p.t., following a 16 hr fast, mice were intravenously injected with 15% Triton WR1339 at a
dose of 500 mg/kg. Plasma (from 100 ul of blood) was collected hourly for 4 hr and TG measured. (A) Wild-type mice, 7 days p.t. with adenovirus
knockdown vector expressing RNAi for lacZ or Ildr2; (B) Wild-type mice, 7 days post- transduction with adenovirus vector over-expressing GFP or Ildr2.
AUC: area under the curve. Insignificant differences by AUC analysis show that hepatic lipoprotein secretion is unaffected by Triton WR1339
administration in ADKD and ADOX mice.
doi:10.1371/journal.pone.0067234.g004
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and FFA catabolism. Unlike the livers at 3 days p.t., those at 10
days displayed a general suppression of transcripts of genes
mediating both synthesis and oxidation of hepatic lipids. The
general suppression of transcripts of genes mediating both
synthesis and oxidation of hepatic lipids between days 3 and 10
suggests that the accumulation of hepatic lipids due to effects of
inhibition of Ildr2 transcription resulted in secondary suppression
of the expression of these genes.
In ADKD OB animals at 10 days p.t. (Figure 6C), Ildr2
knockdown greatly reduced the expression levels of all transcripts
examined compared to the control (lacZ) animals. These effects
were comparable, though more extensive and proportionately
greater, than in the corresponding studies of WT animals, possibly
reflecting, in part, the consequences of pre-existing hepatic
steatosis.
In livers of ADOX WT mice at 3 days p.t. (Figure 6D), as in
the ADKD livers, in the context of an increase in TCH content
(and a trend towards increased TG), transcript levels of genes
mediating the synthesis of these molecules were generally reduced,
although transcript levels of some fatty acid oxidation genes were
slightly increased. However, at 10 days p.t. (Figure 6E), transcript
levels of genes related to glucose metabolism and acylglyceride
synthesis were increased.
In livers of ADOX OB animals at 10 days p.t. (Figure 6F), the
very high levels of lipid accumulation due to the obesity of these
animals were reduced by over-expression of Ildr2. In association
with this reduction, levels of transcripts related to neutral lipid
synthesis and cholesterol are increased, suggesting ‘‘relief’’ of the
secondary suppression imposed by lipid accumulation as men-
tioned above [25].
ER Stress Pathways
The apparent fixed location of ILDR2 in the ER (see Figure 2)
raises the possibility that the protean effects of hypomorphism for
this gene might be related to a role in the mediation of ER stress
responses [12]. Such a role would not be inconsistent with an
independent effect on lipoprotein metabolism [26]. Accordingly,
we examined transcription rates of canonical members of the ER
stress response pathways [27].
In ADKD WT animals at 3 days p.t., expression of ER stress
effectors Perk, Atf6, and Ire1 was slightly reduced, while expression
of transducers Atf4 and Chop was increased. In general, Ildr2 over-
expression was associated with increased expression of ER stress
pathway genes, while Ildr2 knockdown was associated with
decreased expression. Effects were greater at 10 days than at 3
days p.t.
Increases in hepatocyte lipids activate ER stress pathways [28–
30], and activation of ER stress pathways increases hepatic lipid
deposition [31–33]. Given these reciprocal interactions, and the
relatively extended time course over which these studies were
conducted, it is not possible to assign causal primacy to either the
effects on lipid synthesis or ER stress responses. The data are also
consistent with the possibility that ILDR2 has primary effects on
both processes. Experiments conducted in isolated hepatocytes (see
Figure 7) demonstrate that in vitro knockdown of Ildr2 modestly
increases ER stress-related transcripts over a 48-hr period. Longer
term, these responses may be exhausted [34,35]. The apparent
paradox of increased ER stress responses in both ADKD and
ADOX hepatocytes may be due to the former’s reflecting the
response to increased cellular lipids, and the latter to direct
interactions of the ILDR2 molecule with elements of the ER stress
pathways. The increase in ER stress molecules is presumably
partially protective [36–38].
Figure 5. FPLC analysis of plasma lipoprotein fractions in ADKD and ADOX WT mice. At 7 days p.t. with either ADKD or ADOX vectors,
plasma from 6 wild-type mice was collected, pooled and TCH and TG profiles were analyzed by FPLC using Sepharose 6 Fast Flow columns. HDL,
high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very low-density lipoprotein. (A) TCH profile in wild-type mice, 7 days p.t. with
adenovirus knockdown vector expressing RNAi for lacZ or Ildr2; (B) TCH profile in wild-type mice, 7 days p.t. with adenovirus vector over-expressing
GFP or Ildr2; (C) TG profile in wild-type mice, 7 days after adenovirus knockdown vector expressing RNAi for lacZ or Ildr2; (D) TG profile in wild-type
mice, 7 days p.t. with adenovirus vector over-expressing GFP or Ildr2. These experiments show an increase in plasma TG (as VLDL) in ADKD mice but
not in ADOX mice. TCH shifts in ADKD mice from HDL to LDL and VLDL, while in ADOX mice the decrease in HDL is accompanied by an increase in
VLDL only.
doi:10.1371/journal.pone.0067234.g005
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Short-term Effects of Ildr2 Expression on Lipid
Metabolism and ER Stress Pathways in Hepatocytes
ER stress can affect lipid metabolism and vice versa [31,39,40],
and molecules such as XBP1 can independently affect both
pathways [26]. In an effort to disarticulate – by shortening the
experimental time course - possible contributions of ILDR2 to ER
stress response mechanisms, we transduced C57BL/6J mouse
primary hepatocytes for 24 hr with Ildr2 ADKD and ADOX
adenoviral vectors and examined cellular lipid content (Table 8)
and expression of genes of lipid biochemical and UPR/ER stress
pathways (Figure 7).
In the ADKD cells, TG and TCH content were increased,
consistent with the changes seen in the in vivo studies. Only slight
changes were seen in the transcripts analyzed, with no indication
of primacy of Ildr2 knockdown effects on either lipid synthesis or
ER stress genes (Figure 7A). In the ADOX cells, TG and TCH
content were reduced in the context of large, reciprocal changes in
both lipogenesis, where Ldlr and Srebp1c decreased, and ER stress
effectors, where Atf6 and Ire1 increased (Figure 7B). The
comparable magnitude of these changes makes it difficult to
assign primacy, but is consistent with a role for Ildr2 in both
pathways. If these in vitro data at 24 hr are viewed in the context of
the 3 and 10 day in vivo studies, it is apparent that there are strong
temporal effects of responses of the ER stress pathways, and that
the responses are influenced by intercurrent processes, probably
lipid deposition per se.
Effects of Feeding Status, Diet, and ob Genotype on Ildr2
Expression
Hepatic lipid homeostasis is strongly affected by fasting and
refeeding and by diet [41]. To study their effects on Ildr2, we
compared levels of Ildr2 expression in livers of WT mice fed either
chow or a high-fat diet (Figure 8). These results show that feeding
status (the difference between fasted and refed mice) had little
effect on Ildr2 expression, whereas obesity achieved by feeding a
high-fat diet, increased Ildr2 levels by 3.6 fold (Figure 8A). To
determine if this effect was leptin-dependent, we also analyzed
Ildr2 expression in livers of OB (leptin-deficient) mice. These mice
showed a 3.7 fold increase in Ildr2 expression compared to age-
matched WT controls (Figure 8B). The large increases in ildr2
Figure 6. Relative expression of selected genes in ADKD and ADOX WT and OB mice. 10-week-old B6 male mice were chow-fed,
intravenously injected with ADKD and ADOX vectors and sacrificed at 3 days p.t, following a 12-hr fast. Expression levels were determined by qPCR
normalized to expression levels of the 36B4 housekeeping gene. Fold changes are relative to the GFP control in the same state as the Ildr2 (either
fasted or refed compared to fasted or refed). * indicates p,0.05; ** indicates p,0.01 (2 tailed t-test). (A) Expression in wild-type mice, 3 days p.t. with
adenovirus knockdown vector expressing RNAi for lacZ or Ildr2; (B) Expression in wild-type mice, 10 days p.t. with adenovirus knockdown vector
expressing RNAi for lacZ or Ildr2; (C) Expression in wild-type mice, 10 days p.t. with adenovirus vector over-expressing GFP or Ildr2; (D) Expression in
wild-type mice, 3 days p.t. with adenovirus knockdown vector expressing RNAi for lacZ or Ildr2: (E) Expression in ob/ob mice, 10 days p.t. with
adenovirus knockdown vector expressing RNAi for lacZ or Ildr2; (F) Expression in ob/ob mice, 10 days p.t. with adenovirus vector over-expressing GFP
or Ildr2. Changes in transcriptional profiles appear to be secondary to changes in lipid content.
doi:10.1371/journal.pone.0067234.g006
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expression, caused by leptin deficiency and high-fat feeding are
presumably secondary – at some level - to the deposition of TG in
the hepatocytes under both circumstances. Given the possible dual
roles of Ildr2, this effect could reflect a role of Ildr2 in ER stress
responses.
Calorimetry
To determine if there were differences in energy expenditure,
physical activity, or metabolic substrate use in the mice in any of
the models used (ADKD and ADOX in both WT and OB), we
performed indirect calorimetry (72-hr) on chow-fed, 10-week-old
WT and OB males, 4 to 5 days p.t. (Figure 9; Table 9).
Figure 7. Relative expression of selected genes in ADKD and ADOX primary hepatocytes. To identify short-term effects of changes in Ildr2
expression, hepatocytes from five 10-week-old B6 mice were extracted, pooled and plated into individual wells and exposed, in triplicate, for 24 hr to
ADOX or ADKD viral vectors. RNA was extracted, transcribed into cDNA, and expression was determined by qPCR. (A) Expression in hepatocytes
transduced with adenovirus knockdown vector expressing RNAi for lacZ or Ildr2; (B) Expression in hepatocytes transduced with adenovirus vector
over-expressing GFP or Ildr2. These results recapitulate those seen the in vivo studies.
doi:10.1371/journal.pone.0067234.g007
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There were no differences in rates or patterns of 24-hour energy
expenditure in WT mice between knockdown and control (data
not shown). However, in WT (Figure 9A) and OB (Figure 9C)
ADKD mice, the nocturnal respiratory exchange ratio (RER) was
7% lower vs. controls, indicating that, at night, the ADKD mice
preferentially oxidize fat to a greater extent than the WT mice. In
WT (Figure 9B) and OB (Figure 9D) ADOX animals, the RER
was not significantly different between the two groups at any time,
although the OB mice had a slightly higher RER during the dark
period. These data are consistent with hepatic lipid content
influencing systemic fuel oxidation: higher fat content increasing
fatty acid oxidation, resulting in a lower RER.
ipGTT (intraperitoneal Glucose Tolerance Tests)
To assess systemic effects of changes in hepatic lipid and
glycogen content on peripheral glucose homeostasis, we performed
ipGTT on chow-fed, 10-week-old WT and OB males, 7 days p.t.
with Ildr2 ADKD and ADOX constructs (Figure 10). Surpris-
ingly, no differences in systemic glucose tolerance were detected in
ADKD or ADOX animals versus either their respective controls,
or each other. Consistent with these findings, HOMA IR values
based on data obtained at the time of sacrifice of ADKD and
ADOX mice (at 10 days p.t.) were not significantly different (see
Table 2). Thus, large changes in hepatic lipid content were not
accompanied by changes in systemic glucose/insulin homeostasis.
This finding has implications for the possible mechanism(s)
underlying the effects of Ildr2 on hepatic lipid synthesis and
handling.
Discussion
Based upon manipulation of levels of expression of Ildr2 in liver
and isolated hepatocytes using ADKD and ADOX constructs, we
conclude that ILDR2 is an ER membrane protein that participates
in cellular lipid synthesis and responses to ER stress. The most
salient phenotype in the ADKD mice is TG accumulation,
accompanied by increased hepatic and plasma cholesterol and a
mix of micro- and macro-vesicular lipid droplets in periportal
hepatocytes. Overexpression of Ildr2 in ob/ob mice substantially
rescued their hepatic steatosis, as Ildr2 over-expressing mice had
significantly decreased hepatic TG and TCH and reduced
periportal vacuolar deposition.
Despite the excess lipid in the livers at 10 days p.t., transcript
levels for major lipogenic and fat-oxidative genes were reduced in
ADKD mice and up-regulated in ADOX mice. At 3 days p.t.,
several of these genes showed changes in expression in the opposite
direction, suggesting that down-regulation in ADKD mice at 10
days p.t. may have been a response to excess lipid accumulation.
These changes in transcriptional profiles are likely secondary to
the respective increased/decreased lipid content of the hepato-
cytes. Also relevant in considering the molecular pathogenesis of
the steatosis in the ADKD animals is the absence of major changes
of circulating TG or cholesterol in these animals, their apparently
normal rates of hepatic TG secretion, and the absence of
significant changes in glucose or insulin homeostasis. In ADKD
mice, reduced hepatic VLDL/IDL/LDL clearance and increased
circulating IDL/LDL cholesterol suggests a reduction in hepatic
LDL receptor-mediated clearance of those lipoproteins, consistent
with reduced expression of hepatic LDL receptor [42,43].
Table 8. Triglyceride and cholesterol content of ADKD and ADOX hepatocytes.
ADKD ADOX
lacZ Ildr2 P-value GFP Ildr2 P-value
Triglyceride (mg/g protein) 103.162.3 119.463.4 0.019 105.563.9 92.761.3 0.056
Cholesterol (mg/g protein) 7.5860.37 8.4560.40 0.083 8.4360.96 6.6260.45 0.081
Hepatocytes from 5, 10-week-old B6 mice were extracted, pooled and plated into individual wells and exposed for 24 hr to either the ADOX or ADKD (or empty vector
control) virus in triplicate. Cells were lysed and triglyceride and total cholesterol were determined.
doi:10.1371/journal.pone.0067234.t008
Figure 8. Expression of Ildr2 in liver is increased by adiposity through high-fat diet or leptin deficiency. Expression of Ildr2 was
determined by qPCR, normalized to 36B4 in mice sacrificed after either fasting for 24 hr or after fasting for 24 hr and followed by a 12-hr refeeding
period. (A) Wild type B6 mice at 6 weeks of age were fed ad libitum either chow or a high fat diet (60% of kcal from fat) for 3 additional months. (B)
Chow-fed wild type B6 and leptin-deficient OB mice (B6.Cg-Lepob/J) were purchased at 9 weeks and sacrificed at 10 weeks of age. Wild-type mice fed
a high fat diet and genetically obese mice showed a similar (3.6 to 3.7-fold) increase in Ildr2 liver expression compared to age- matched wild-type
mice (p value ,.01 ) regardless of feeding status.
doi:10.1371/journal.pone.0067234.g008
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Lipid accumulation in the liver is commonly associated with
liver and/or systemic insulin resistance and resultant hyperglyce-
mia. Indeed, hepatic steatosis is commonly implicated as a
causative factor in these phenotypes that are aspects of the
metabolic syndrome [44–46]. However, in the ADKD animals,
large changes in hepatic lipid content were not accompanied by
changes in systemic glucose/insulin homeostasis [47]. Decreased
lipid droplet turnover and/or enhanced traffic of newly synthe-
sized TG from the ER to the cytoplasmic droplets might be related
to the apparent absence of effect of the increased lipid deposition
on glucose/insulin homeostasis. Since neither insulin resistance
nor hyperglycemia was present in the ADKD mice (similar in this
regard to the phenotype of mice hypomorphic for hepatic Atgl)
[24,48,49], we investigated other mechanisms relating Ildr2 to
hepatic steatosis.
Localization of ILDR2 in the ER membrane, up-regulation of
ER stress markers in the livers of ADOX mice and down-
regulation in ADKD mice, along with the emerging relationship
Figure 9. Respiratory Exchange Ratio (RER) in ADKD and ADOXWT and OBmice.Mice were chow-fed, 10-week-old B6 (WT) or B6.V-Lepob/J
(OB) males, at 4 to 5 days p.t. with adenovirus knockdown vectors expressing RNAi for lacZ or Ildr2 or with adenovirus vectors over- expressing GFP or
Ildr2. Data shown are mean 6 SEM (8 mice per group) and run in a TSE systems indirect calorimeter for 48 hr. (A) WT ADKD; (B) OB ADKD; (C) WT
ADOX; (D) OB ADOX. ADKD mice show decreased RER at night, whereas ADOX mice show no differences, day or night. AUC calculations are shown in
Table 9.
doi:10.1371/journal.pone.0067234.g009
Table 9. Area under the curve calculations for calorimetry in Figure 9.
wild-type ob/ob
ADKD ADOX ADKD ADOX
AUC lacZ Ildr2 GFP Ildr2 lacZ Ildr2 GFP Ildr2
24-hr 43.260.6 40.860.6* 42.160.6 42.060.4 42.060.8 40.961.4 39.560.8 40.361.3
Day 20.160.5 19.260.5 19.660.4 19.760.2 19.860.4 20.060.6 19.160.3 19.560.6
Night 23.160.3 21.660.3** 22.460.2 22.360.3 22.360.6 20.960.8 20.560.5 20.860.7
*p,0.05;
**p,0.01; AUC, area under the curve.
doi:10.1371/journal.pone.0067234.t009
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between hepatic lipid accumulation and ER stress in several
metabolic disorders, including obesity, hepatic steatosis and type II
diabetes [16,31,50], suggest that ILDR2 might have a role in
cellular ER stress responses.
Three known pathways provide mechanisms whereby Ildr2
regulation of hepatocyte lipid metabolism and ER stress could be
achieved:
(1) ILDR2 has a primary role in ER function, where ER stress
produced by Ildr2 knockdown leads to lipid accumulation.
Overexpression of the ER stress chaperone BIP (GRP78) in
ob/ob mice (as with Ildr2) reverses hepatic steatosis [51], and
hypomorphic expression of UPR modulators Atf6, Ire1a, Chop,
and Crebh in mouse models cause hepatic dyslipidemia
[32,33,52,53].
(2) ILDR2 has a primary role in lipid metabolism, where Ildr2
knockdown leads to lipid accumulation, which causes ER
stress. Excess intracellular fatty acids induce ER stress in the
liver via pathways affecting ER membrane integrity and
calcium homeostasis [40,54], increasing Chop expression [55],
inducing PERK signaling [28] and stimulating CREBh-
induced inflammation [56,57]. Additionally, fatty acid–
binding protein-4 (aP2) has a primary role in lipid metabolism
and mitigates ER stress in macrophages [39].
(3) ILDR2 is independently involved in both ER function and
lipid metabolism, as has been suggested for the ER stress-
related gene, Xbp1, a key transcription factor and effector of
the UPR which is spliced by IRE1a in response to ER stress.
Xbp1 KO mice show reduced hepatic TG secretion and
decreased fatty acid oxidation, along with down-regulation of
key hepatic lipogenic genes [26]. While we have not shown
that ILDR2 is a transcription factor, by acting on downstream
signaling targets, including transcription factors, it could
independently affect the UPR and lipid metabolism.
The broad down-regulation of lipid metabolism and ER stress
genes in the ADKD mice at 10 days p.t. is consistent with studies
of pharmacologically-induced ER stress, in which expression of
genes involved in lipid metabolism and ER stress initially increases
and then declines. This pattern has been observed both in vitro and
in vivo for spliced Xbp1, Chop, Bip, lipogenic transcription factors,
lipid droplet proteins, and TG synthesis genes [34]. If Ildr2
knockdown induces ER stress in these mice, then by 10 days we
may be observing the decline of previously up-regulated ER stress
and metabolic genes.
Since it remains uncertain, which gene expression effects are
primary in the pathogenesis of the hepatic steatosis, and which
may be responses to the steatosis per se, the data obtained in the 3
and 10 day adenovirus transductions should be cautiously
interpreted. Absence of a clear pattern in the differential responses
of the canonical UPR pathways seen in the studies reported here
suggests that these variable responses may reflect differences in the
timing of the responses of specific molecules and pathways coupled
with secondary effects of the accumulation of hepatic lipids [58].
Ildr2-mediated effects on lipid homeostasis and ER stress
responses could account for both the hepatic steatosis observed
in the ADKD animals reported here, and the reduced b-cell mass
and accompanying glucose intolerance in the Chr 1 B6.DBA ob/ob
congenic animals [1]. Perk–null mice develop ER stress specifically
in the b-cell, with morphological abnormalities within the
pancreatic ER leading to loss of b-cells, and hypoinsulinemic
hyperglycemia [59]. Deregulation of lipid metabolism in a b-cell
line impaired insulin secretion [60].
In a recent study, ILDR2, along with ILDR1 and ILDR3, was
localized to tricellular junctions on the PM of mouse epithelial cells
– specifically fibroblasts, mammary and retinal epithelia, and
choroid plexus [61]. The authors propose that these molecules
mediate macromolecular access through these ‘‘tight junctions’’.
However, no specific effort was made to visualize ILDR2 or other
ILDR molecules in the ER. As has been described for the
thyrotropin-releasing hormone receptor, which is localized to the
PM in pituitary cells but to the ER and Golgi in non-pituitary cells
[62], ILDR2 may localize primarily to the PM in epithelial cells,
and to the ER in other cell types (e.g. hepatocytes, neurons, b-
cells). Alternatively, subcellular distribution of members of this
family of proteins may reflect cell type-specific splicing patterns, as
reported for BAT3 [63].
Materials and Methods
Ethics Statement
All protocols were approved by the Columbia Institutional and
Animal Care Use Committee (Permit Number: AAAC3125).
Animal Care
Mice were housed in a vivarium maintained on a 12 hr –12 hr
light-dark cycle, with ad libitum access to 5058 Purina PicoLab
Mouse Diet 20 (9% fat) and water, unless otherwise stated. All
mice were sacrificed at the same time-of-day (1000–1200 hr).
Strains
Male 9-week-old C57BL/6J (B6) (Stock number 000664) and
B6.V-Lepob/J (ob/ob) (Stock number 000632) mice were obtained
from Jackson Laboratories (Bar Harbor, ME) and allowed to
adjust to conditions in our local colony for 1 week prior to starting
experiments. Mice used to study the effects of feeding status and
diet (Figure 8A) were fed high-fat chow (60% kcals from fat) at
Jackson Laboratories from 6 weeks of age until purchase at 18
Figure 10. ipGTT in WT and OB mice 7 days p.t. At 7 days p.t. with
adenovirus knockdown vectors expressing RNAi for lacZ or Ildr2 (left) or
with adenovirus vectors over-expressing GFP or Ildr2 (right), the 10-
week-old chow-fed male B6 mice that were used in the 10 day
experiments were injected intraperitoneally after 12 hr fast with 2g/kg
glucose. The mice used in this experiment are the same mice that on
which indirect calorimetry was conducted on day 5 p.t. (A) WT ADKD;
(B) OB ADKD; (C) WT ADOX; (D) OB ADOX. In both ADKD and ADOX
animals, IPGTT was unaffected.
doi:10.1371/journal.pone.0067234.g010
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weeks of age. Mice were fed ad libitum high-fat chow (Research
Diets D12492i) for 4 additional weeks.
Metabolic Parameters
Body mass and composition. Weight was measured with a
Vicon Vic-212 integrating laboratory scale (Acculab). Fat and lean
mass were measured with a Minispec TD-NMR Analyzer (Bruker
Optics), calibrated using mouse carcasses [64].
Serum. Blood was collected at sacrifice. Plasma was analyzed
for glucose using an Autokit Glucose (Wako), for TG using an L-
Type TG M Color A (Wako), for TCH using Cholesterol E
(Wako), for FFA using HR Series NEFA-HR(2) Color Reagent B
(Wako) and insulin using an Ultra Sensitive Mouse Insulin ELISA
Kit (Crystal Chem). Glucose in living mice was measured with a
FreeStyle Lite portable glucose meter (Abbott) using 3 ml blood
from a capillary tail bleed. IPGTT was performed in the morning
after overnight fast. Blood for fasting glucose analysis was collected
by tail bleed. Mice were injected with 2 mg/g of glucose using a
50 mg/ml solution in autoclaved water. Blood was collected at 5,
15, 30, 60, and 120 minutes and glucose was measured with the
Autokit Glucose.
Plasma Lipid Profile and Triton Experiment
250 ml of pooled plasma from 6 mice fasted for 5 hr was used
for FPLC analysis using 2 Sepharose 6 Fast Flow columns in series
(Amersham Biosciences). The buffer contained 100 mM Tris and
0.04% NaN3, pH 7.5; a flow rate of 0.7 ml/min was used. TCH
and TG levels of FPLC fractions were measured using Wako
enzymatic kits. To block clearance of nascent lipoproteins, these
mice were then injected with Triton WR1339 (0.5 mg/g body
weight; Sigma-Aldrich) via tail vein. Blood samples were collected
at 0, 30, 60, and 120 min post-injection. Initial plasma samples
were used for TG quantification.
Liver Glycogen
Liver fragments (0.1–0.2 g) were digested in 1 ml of 30% KOH
at 95uC for 30 min; 0.2 ml of 2% Na2SO4 and 3.2 ml of 70%
ethanol were added and the mixture was centrifuged for 30 min at
6800 RCF. Pellets (containing glycogen) were washed with 70%
ethanol and resuspended in 0.5 ml of 0.2 M acetate buffer; 0.1 ml
of the solution was incubated for 30 min at 55uC with 5 ml of
amyloglucosidase (Sigma) and then incubated 5 min at 37uC with
Autokit Glucose (Wako Diagnostics, Richmond, VA). Glycogen
content was expressed as mg of glucose/g of wet liver.
Liver Lipids
Whole lipids were extracted by Bligh-Dyer extraction [65]. In
brief, 1.5 ml of chloroform:methanol (1:2, v/v) with 0.4 ml of PBS
was added to liver pieces (0.1–0.2 g) in a screw-capped glass test
tube and mixed vigorously for 1 min. Vigorous mixing followed
successive additions of 0.5 ml chloroform and 0.5 ml H2O. The
mixture was centrifuged at 1800 RCF for 5 min and the lower
(organic) phase, containing whole lipids, was collected and stored
at 220uC until assay. TCH and TG were determined with a
colorimetric kit (Wako; Cholesterol E 439-17501; L Type TG 461-
08892 and 461-09092).
HOMA-IR
HOMA2-IR (homeostasis model assessment-estimated insulin
resistance) and HOMA-2-B% (homeostasis model assessment-b-
cell function) were calculated using the HOMA calculator, http://
www.dtu.ox.ac.uk/homacalculator/index.php, based on the non-
linear updated HOMA2 model [66], which takes account of
variations in hepatic and peripheral glucose resistance, increases in
the insulin secretion curve for plasma glucose concentrations
.10 mmol/L (180 mg/dL) and the contribution of circulating
proinsulin.
Energy Expenditure
Energy expenditure was measured with a LabMaster-CaloSys-
Calorimetry System (TSE Systems, Bad Homburg, Germany). O2
and CO2 measurements were taken every 26 min during a 72 hr
period from 32, 10-week-old male mice (8 ADOX, 8 ADOX
control, 8 ADKD, and 8 ADKD control). Mice were injected with
the adenovirus on day 0 and placed in calorimeters from days 5–7.
Because of stress related to transfer to the calorimetry chambers,
only measurements taken within the last 48 hr were used to
calculate total 24-hr energy expenditure (TEE; in kcal/24-hr) and
respiratory exchange rate (RER=VCO2/VO2). Resting energy
expenditure (REE in kcal/24-hr) was defined as the1-hr period of
lowest energy expenditure. This coincided with the 1 hr of lowest
total ambulatory activity (generally early afternoon), during the 48-
hr period; this value was extrapolated to 24 hr. Non-resting energy
expenditure (NREE) was calculated as the difference between
TEE and REE (NREE=TEE – REE). Physical activity was
measured by an infrared beam system integrated with the
LabMaster system. Total activity (beam breaks) in X, Y, and Z
axes was recorded every 26 min. The system is designed to
differentiate between fine motor movement (defined as a single X
or Y axis beam break), ambulatory movement (defined as the
simultaneous breaking of two adjacent X or Y beams), and
rearing, defined as the breaking of the Z axis infrared beam. Lights
were off at night from 1900 to 0700 hr.
Adenovirus Studies
Adenoviral expression vectors. Adenoviruses were pre-
pared and amplified with the ViraPower Adenoviral Expression
System (Invitrogen). Viral titers were determined by plaque-
forming assays on HEK 293A cells. PCR-amplified, full-length
Ildr2-cDNA was subcloned into the pENTR/D-TOPO vector
using the pENTR Directional TOPO Cloning Kit (Invitrogen).
After verifying the sequence, inserts were transferred into the
pAd/CMV/V5-DEST vector by the Gateway system using LR
Clonase II Enzyme Mix. Sequences corresponding to the shRNAs
for Ildr2 and lacZ were cloned into pBlock-it (Invitrogen). The
sequence of the shRNA for Ildr2 was: 59-cac cGT TCA AAT
CCT ACT GCC Aga cgt gtg ctg tcc gtC TGG CAG TAG GAT
TTG AAC-39, where the 59 uppercase 18-nucleotide sequence
corresponds to the coding strand in exon 2 for the amino acid
sequence FKSYCQ.
Virus purification. To obtain virus particles, plasmids were
linearized by Pac I digestion and transduced into HEK 293A cells
with Lipofectamine 2000 using Opti-MEM medium. The
transduced HEK 293A cells were incubated at 37uC in a 6 cm
dish until the cells started to die (about 10 days). The cells and
supernatant were harvested in a 50 ml tube and subjected to 3
freeze-thaw cycles to lyse the cells. The suspension was centrifuged
at 1800 RCF for 15 min to eliminate cellular debris. The
supernatant was collected and used to transduce a new 10 cm
dish of HEK 293A cells. This process (grow, lyse, centrifuge,
transduce a larger number of cells) was repeated until 20, 15-cm
dishes, were incubated simultaneously. The cells and supernatant
were collected and spun at low speed (200 RCF) for 2 min. The
cells and 5 ml of supernatant were then subjected to 3 freeze-thaw
cycles to lyse cells, followed by centrifugation at 1800 RCF for
15 min. A CsCl step gradient was set up with a lower layer of 4 ml
of 1.4 g/ml CsCl and an upper layer of 3 ml of 1.2 g/ml CsCl.
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5 ml of supernatant was over-layered and ultracentrifuged at
65,000 RCF for 90 min at 4uC. The 1.2 g/ml cesium chloride
layer, containing virus, was extracted and dialyzed vs. 10 mM
Tris/HCL at pH 8.0. Viral concentration was determined by
OD260 assay.
Injection. Recombinant viruses were administered via tail
vein injection and mice were sacrificed 3 days or 10 days p.t.
Real-Time qPCR. RNA was extracted with TRIzol acid-
phenol reagent (Invitrogen) and purified with on-column DNase
digestion using RNeasy Mini Kit (Qiagen). RNA integrity was
verified by visual inspection of ethidium bromide stained
electrophoresis gels and by OD260 nm/OD280 nm.1.9 and
OD260 nm/OD230 nm.2.0. First strand cDNA synthesis was
performed using 1 mg of total RNA each and the Sprint RT
Complete-Random Hexamer kit (Clontech) according to the
manufacturer’s instructions. Reverse transcription (RT) followed
by PCR was used to analyze mRNA abundance in response to
treatments. Primers for genes were designed to produce an
amplification product which spanned at least one exon using the
Universal Probe Library Assay Design Center (www.
universalprobelibrary.com, Roche Applied Sciences); primers were
synthesized by Invitrogen. qPCR analysis was performed on a
LightCycler 480 (Roche) using the LightCycler 480 SYBR Green I
Mastermix (Roche).
Primers for PCR





The first TCA in the reverse is the stop codon. The ATG in the
forward is the start codon. Primers used in expression analysis are
shown in Table 10.
Construction of Tag Protein Fusions
N-terminal 3xFLAG Ildr2 fusion construct. The Ildr2 open
reading frame from exon 2 was subcloned into p3xFLAG-CMV-8
(N-terminal FLAG with PPT LS, Sigma-Aldrich # E4151-20UG).
Ildr2 was amplified using a forward primer on the sequence coding
for the first amino acids of exon 2 with a HindIII site (59 ATT
TAC AAG CTT CAG GTC ACA GTG CCT GAC AAG AAG
AAG GT39), and a reverse primer with an in-frame stop codon
and EcoR1 restriction site at the end of Ildr2 last exon (59- CAT
GCA GAA TTC TCA GAC TAC AAG GGA CAT CCT G -39).
The destination vector and the PCR amplified Ildr2 sequence were
digested with HindIII and EcoR1 (NEBiolabs) in NEBuffer EcoR1
and BSA at 37uC for 60 min, purified and ligated.
C-terminal -tagged ILDR2 mYFP construct. The ildr2 open
reading frame from exon 1 was subcloned into pmEYFP-N1
(Clontech # 6006-1). Ildr2 was amplified using a forward primer
on exon 1-including Kozak sequence- with a site for the restriction
enzyme NheI (59- ATC TTG CTA GCG GTA ATG GAT AGG
GTC GTG TTG G-39), and a reverse primer that bypass the stop
codon and an EcoRI restriction site (59- CAT GCA GAA TTC
GGA CTA CAA GGG ACA TCC TG-39). The destination vector
and the PCR-amplified Ildr2 sequence were digested with Nhe and
EcoRI (NEBiolabs) in NEBuffer EcoRI+BSA at 37uC for 60 min,
purified and ligated.
Isolation of Hepatocytes
Hepatocytes were pooled from 5, 10-week-old C57BL/6J mice.
The mice were anaesthetized with cocktail containing ketamine
(100 mg/kg) and xylazine (20 mg/kg) and then laparotomized to
expose the liver and the portal vein. A 25G winged needle
attached to a 50 ml syringe filled with 37uC EGTA-Hanks
solution (Hanks Balanced Salt Solution, Gibco; EGTA final
concentration 0.5 mM) was inserted into the portal vein and
clipped in place with a clamp at the root of the mesentery and the
needle. After cutting the inferior vena cava, the liver was perfused
with 30 ml EGTA-Hanks. Using a fresh syringe, the liver was then
perfused with 20 ml of a solution containing collagenase (5 mM
CaCl2 in Hanks with 1 mg/ml of collagenase type II Gibco #
17101-015) being careful not to inject bubbles. Liver was excised
and placed in a 10 cm sterile dish on ice with 2–3 ml of
collagenase solution and minced with scissors to remove visible
blood clots. Minced livers were pooled and incubated for 5–
10 min at 37uC and homogenized by pipetting up and down 20–
30 times. Then 20 ml of RT Hanks balanced salt solution was








































PCR primers used in experiments described in Table 1, Figure 6, and Figure 7.
doi:10.1371/journal.pone.0067234.t010
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added to the dish and mixed. The suspension was filtered through
sterile gauze into a 50 ml conical tube, spun 1 min at 200 RCF at
RT and aspirated to remove supernatant. Cells were resuspended
in 20 ml Gibco HG medium (with 10% FBS, 1% Penicillin
Streptomycin, 10 nm DEX, 100 nm insulin, and 0.1% Fungizone)
and pipetted up and down 5 times. The suspension was filtered
through a 100 um Nylon cell strainer (BD Falcon REF352360)
and collected in 50 ml conical tube. The filtrate was centrifuged
again at 200 RCF for 1 min at RT and aspirated to remove the
supernatant. Cells were resuspended in 25 ml of Gibco HG
medium and gently pipetted. Cells were counted with an
Invitrogen Countess using trypan blue staining and then
distributed at 36106 cells per 10 cm plate and incubated overnight
at 37uC in a humidified 5% CO2 incubator before administering
virus.
Cell Line Studies
Cell microscopy, image acquisition. Cell cultures were
prepared and maintained according to standard cell culture
procedures. Hepa1c1c7 and GT1-7 cells were maintained in
Dulbecco’s Modified Eagle Medium supplemented with 10% fetal
calf serum using BD Falcon T75 cell culture flasks. For transient
transfection, cells were harvested by Trypsin/EDTA digestion,
seeded on coverslips (16105 per coverslip) and incubated for 24 h
in a cell culture incubator at 37uC and 5% CO2. Transfection of
plasmid DNA for GFP-tagged ILDR2 was performed with
Lipofectamine 2000 according to the manufacturer’s instructions.
In brief, cells were incubated with 500 ng plasmid DNA and
1.25 ml Lipofectamine 2000 in Opti-MEM (24-well plate format)
over night before being analyzed. Transfection was up-scaled
accordingly if other plate formats were used.
Confocal images. Transduced cells were washed with PBS,
fixed in 4% paraformaldehyde at room temperature (rt) for
15 min, washed again with PBS, permeabilized with 0.1% Triton-
X 100 (2 min at rt) if necessary and incubated with blocking buffer
(5% normal goat serum and 0.05% Tween 20 in PBS) for 30 min.
For immunostaining, cells were incubated overnight at 4uC with
the corresponding specific antibody diluted in blocking buffer,
washed with PBS, incubated for 1 hr at rt with 2 mg/ml Alexa
Fluor 546 goat anti-mouse secondary antibody diluted in blocking
buffer washed with PBS and mounted in ProLong Gold antifade
reagent with DAPI as a nuclear staining marker. Samples were
analyzed with a Confocal Laser Scanning Microscope (TCS SP2,
Leica, Germany). When fluorescent proteins were used, GFP was
excited at 488 nm and fluorescence was detected at 500–540 nm.
YFP was excited at 514 nm and fluorescence was detected at 520–
560 nm. DsRed was excited at 557 nm and fluorescence was
detected at 592 nm. Alexa Fluor 546 was excited with the 543 nm
line of the helium laser and fluorescence was detected at 555–
700 nm. Cells were imaged with a 63.0x/1.25 HCX PL APO
objective lens. Images were processed with Adobe Photoshop
software. Images shown are stacks of several confocal sections.
siRNA reverse transfection. RNA interference-mediated
gene knockdown was achieved using custom Stealth RNAiTM
siRNA designed using the BLOCK-iTTM RNAi Designer software
(Invitrogen), and its correspondent controls.10 nM RNAi duplex
was diluted in Opti-MEMH I Reduced Serum Medium (Invitro-
gen) and 5 ul of LipofectamineTM RNAiMAX (Invitrogen) was
added to each well containing the diluted RNAi. After mixing, the
complexes were incubated for 20 min at rt. After incubation,
approximately 0.15–0.256106 cells per well in complete growth
medium without antibiotics were added to the wells containing the
siRNA-lipid complexes. Cells were then cultured in normal growth
medium processed for RNA or protein extraction as indicated by
experimental procedure.
Western blotting. Cells were lysed in M-PER Mammalian
Protein Extraction reagent (Thermo Scientific) with protease
(Calbiochem) and phosphatase inhibitor (Thermo Scientific).
Equivalent amounts of protein (100 to 400 mg) from each sample
were diluted in 16 LDS sample buffer (Invitrogen) containing
100 mM DTT and incubated for 10 min at 70uC. After
denaturing, the mixture was cooled at rt for at least 15 min and
the protein was resolved by SDS-PAGE. The gel was transferred
onto polyvinylidene fluoride (PVDF) membrane and blocked by
incubation for 1 hr at rt in a solution 5% bovine serum albumin
fraction V (BSA) in Tris-buffered saline with Tween (TBST) at
pH 7.4, followed by overnight incubation at 4uC with primary
antibody in 5% BSA/TBST. Following 3 15-min washes with
TBST, membranes were incubated for 1 hr at rt with the
corresponding secondary antibody and washed 3 more times in
TBST. Membranes were developed using a chemiluminescence
assay system and proteins were visualized using Kodak exposure
film. Membranes were stripped using RestoreTM PLUS Western
blot stripping buffer (Thermo Scientific) with vigorous agitation for
10 min at rt, followed by 3 TBST washes.
Statistical Analysis
Two tailed T tests were performed using Microsoft Excel.
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